ISPOR 2026 Home
  • About
    • News Center
    • Social Feed
  • Program
    • Program
    • Posters
    • Student Program
    • Learning Formats
    • Program Committee
    • Plenary Sessions
  • Exhibits & Sponsorship
    • Exhibitor Directory
    • Sponsors
    • Media Partners
  • Photo Gallery
large-circle

ISPOR 2026

Sunday, May 17 - Wednesday, May 20

  • Home
  • Events
  • Past Conferences
  • ISPOR 2026
  • Program
  • Program
  • Presentation
  • DERIVATION OF MEANINGFUL WITHIN-PATIENT CHANGE (MWPC) THRESHOLDS OF THE EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE QUESTIONNAIRE C30 (EORTC QLQ-C30) PHYSICAL FUNCTIONING (PF) SCORES FROM THE ASCENT-03 TRIAL

    Apr 9, 2026, 18:05 PM
  • BARRIERS AND FACILITATORS TO PATIENT ENGAGEMENT WITH PATIENT-REPORTED OUTCOME MEASURE COMPLETION IN ROUTINE RADIATION ONCOLOGY CARE

    Apr 9, 2026, 18:05 PM
  • EVALUATING AGREEMENT BETWEEN PATIENT-REPORTED CLINICAL TRIAL DATA FROM ADOPT PGX AND MEDICARE AND MEDICAID CLAIMS

    Apr 9, 2026, 18:05 PM
  • PATIENT PREFERENCES FOR THE TREATMENT OF BCG-UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER (NMIBC): FINDINGS FROM A UNITED KINGDOM (UK) QUESTIONNAIRE

    Apr 9, 2026, 18:05 PM
  • PATIENT-REPORTED OUTCOMES AFTER KIDNEY TRANSPLANTATION: REAL-WORLD EVIDENCE OF BURDEN POST-TRANSPLANT

    Apr 9, 2026, 17:58 PM
  • PSYCHOMETRIC PERFORMANCE OF EQ-5D-5L INDEX IN ADULTS AND ADOLESCENTS WITH SEVERE ALOPECIA AREATA: EVIDENCE FROM PHASE III TRIAL DATA

    Apr 9, 2026, 17:58 PM
  • HOW SOCIETY VALUES HEALTH: UNEQUAL CONTRIBUTIONS OF PHYSICAL AND MENTAL WELL-BEING TO SOCIAL WELFARE

    Apr 9, 2026, 17:58 PM
  • AGE AND GENDER-SPECIFIC DIMENSIONALITY OF THE SATISFACTION WITH LIFE SCALE

    Apr 9, 2026, 17:58 PM
  • CONSIDERATION OF INDIRECT EFFECTS IN NATIONAL VACCINE EVALUATIONS AND RECOMMENDATIONS: A SCOPING REVIEW

    Apr 9, 2026, 17:32 PM
  • ECONOMIC EVALUATIONS AND VALUE CONSIDERATIONS IN ACIP ROUTINE VACCINE RECOMMENDATIONS: A COMPREHENSIVE REVIEW

    Apr 9, 2026, 17:32 PM
  • COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF THE TRIVALENT ADJUVANTED INFLUENZA VACCINE IN PEOPLE OVER 50 YEARS OF AGE FOR ARGENTINA

    Apr 9, 2026, 17:32 PM
  • POTENTIAL ENVIRONMENTAL AND ECONOMIC IMPLICATIONS OF ROBOTIC ASSISTED SURGERY FOR UROLOGIC ONCOLOGY

    Mar 19, 2026, 15:43 PM
  • DECISION-RELEVANT EARLY HEALTH ECONOMIC MODELLING TO INFORM DEVELOPMENT AND INVESTMENT IN EMERGING HEALTH TECHNOLOGIES

    Mar 19, 2026, 15:43 PM
  • DEVELOPMENT OF THE MEDICAL DEVICE ECONOMIC EVALUATION METHODOLOGICAL QUALITY (DEEM-Q) CHECKLIST

    Mar 19, 2026, 15:43 PM
  • BUDGET IMPACT OF ADOPTING A TRI-LAYER HYBRID SURGICAL MESH FOR VENTRAL HERNIA REPAIR: A U.S. HOSPITAL PERSPECTIVE

    Mar 19, 2026, 15:43 PM
  • COMPARING THE RISK OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS BETWEEN GABAPENTINOIDS AND DULOXETINE

    Mar 19, 2026, 15:42 PM
  • REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY BY CISPLATIN ELIGIBILITY STATUS: A US MULTICENTER CHART REVIEW STUDY

    Mar 19, 2026, 15:42 PM
  • REAL-WORLD SAFETY PROFILE OF PEMBROLIZUMAB VS. NIVOLUMAB AND CETUXIMAB IN ADULTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA: A COMPARATIVE ANALYSIS

    Mar 19, 2026, 15:42 PM
  • REAL-WORLD HEALTHCARE RESOURCE UTILIZATION AND COSTS OF HOSPITAL-ONSET METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS NON-VENTILATOR-ASSOCIATED PNEUMONIA IN U.S. HOSPITALS: 2023-2025

    Mar 19, 2026, 15:42 PM
  • WHEN THERAPIES ARE TARGETED BUT METHODS ARE GUESSING: CLOSING THE GAP IN PRECISION ONCOLOGY EVALUATION

    Mar 18, 2026, 21:38 PM
  • 1 (current)
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »
Quick Links

  • About
  • Media Center
  • Exhibits & Sponsorships
  • Contact Us
Policies & Legal

  • Antitrust Compliance
  • Code of Ethics
  • Diversity Policy
  • Funding Statement
  • Legal Disclaimer
  • Privacy Policy

Subscribe

Join ISPOR


ISPOR–The Professional Society for
Health Economics and Outcomes Research

Copyright © 2018 ISPOR. All rights reserved.

International Society for Pharmacoeconomics and Outcomes Research, Inc

Website Design & Development by Matrix Group